Small bowel adenocarcinomas are rare, histologically diverse tumours and their incidence worldwide is increasing. Despite this, research efforts have received comparatively little attention compared with other cancers with a similar incidence. The authors present an evidence-based approach to present-day management of small bowel adenocarcinoma, describe contemporary challenges and uncover evolving paradigms in the management of these rare neoplasias.
- Kanwal Raghav
- Michael J. Overman
